Annovis Research and Development Expense vs Weighted Average Shares Diluted Analysis

ANVS
 Stock
  

USD 12.20  0.93  8.25%   

Annovis Bio financial indicator trend analysis is way more than just evaluating Annovis Bio prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Annovis Bio is a good investment. Please check the relationship between Annovis Bio Research and Development Expense and its Weighted Average Shares Diluted accounts. Please continue to Trending Equities.

Research and Development Expense vs Weighted Average Shares Diluted

Research and Development Expense vs Weighted Average Shares Diluted Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Annovis Bio Research and Development Expense account and Weighted Average Shares Diluted. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Annovis Bio's Research and Development Expense and Weighted Average Shares Diluted is 0.91. Overlapping area represents the amount of variation of Research and Development Expense that can explain the historical movement of Weighted Average Shares Diluted in the same time period over historical financial statements of Annovis Bio, assuming nothing else is changed. The correlation between historical values of Annovis Bio's Research and Development Expense and Weighted Average Shares Diluted is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research and Development Expense of Annovis Bio are associated (or correlated) with its Weighted Average Shares Diluted. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Weighted Average Shares Diluted has no effect on the direction of Research and Development Expense i.e., Annovis Bio's Research and Development Expense and Weighted Average Shares Diluted go up and down completely randomly.

Correlation Coefficient

0.91
Relationship DirectionPositive 
Relationship StrengthVery Strong

Research and Development Expense

A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.

Weighted Average Shares Diluted

The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPSDil]; determined based on the timing of issuance of shares or units in the period.
Most indicators from Annovis Bio fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Annovis Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Please continue to Trending Equities.As of 06/27/2022, Issuance Purchase of Equity Shares is likely to grow to about 50.4 M, while Selling General and Administrative Expense is likely to drop slightly above 4.8 M.

Annovis Bio fundamental ratios Correlations

Annovis Bio Account Relationship Matchups

Be your own money manager

Our tools can tell you how much better you can do entering a position in Annovis Bio without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Module
Please continue to Trending Equities. Note that the Annovis Bio information on this page should be used as a complementary analysis to other Annovis Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Annovis Stock analysis

When running Annovis Bio price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is Annovis Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis Bio. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
92 M
Return On Assets
-0.44
Return On Equity
-0.74
The market value of Annovis Bio is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis Bio's value that differs from its market value or its book value, called intrinsic value, which is Annovis Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis Bio's market value can be influenced by many factors that don't directly affect Annovis Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.